The New Nicotine Alliance’s international press review focuses on the WHO’s investigation into nicotine, new research data, and European regulatory developments.
The latest international selection from the New Nicotine Alliance highlights that, at the initiative of the Republic of Palau, the World Health Organization (WHO) Expert Committee on Drug Dependence held a hearing on the review of classifying nicotine as a psychotropic substance, which was supported by more than one hundred tobacco control organizations.
In the scientific section, experts criticized a pilot study with only 22 participants and no control group that examined the effects of vaping on lung function. Additionally, data from Belgium highlighted that among Flemish youth, exclusive traditional smoking has decreased to 1.2%, while 9.2% use only e-cigarettes and 13.9% are dual users.
At the European level, the World Vapers’ Alliance (WVA) held an awareness-raising action in front of the European Parliament against the obstruction of harm reduction alternatives. Meanwhile, in France, a bill aimed at banning nicotine-containing vape starter kits failed to pass the parliamentary filter due to procedural reasons.
In brief
- The WHO committee has begun examining Palau’s proposal to classify nicotine as a psychotropic substance.
- Experts dispute the reliability of the lung function study involving 22 participants due to the lack of a control group.
- Among Flemish youth, smoking has fallen to 1.2%, while dual use has reached 13.9%.
- In France, an attempt to ban nicotine starter kits was rejected for procedural reasons.
Source: NNA (vapers.org.uk)
This summary was prepared by artificial intelligence based on the original article.